Skip to main content

Meet the Analyst: Thomas Wakim & John Hester, Bell Potter Analyst

Bell Direct
December 17, 2024

Join us as we conclude our 2024 Meet the Analyst series with a bang. Our Market Analyst, Grady Wulff, sits down with Bell Potter’s analysts John Hester and Thomas Wakim for a comprehensive discussion on the healthcare sector.

From deciphering Neuren Pharmaceuticals (ASX:NEU) share price fluctuations to anticipating the news flow that will share 2025 guidance and identifying why Telix Pharmaceuticals (ASX:TLX) and Clarity Pharmaceuticals (ASX:CU6) are stocks to watch in the new year, John and Thomas cover it all in this final episode of the year.

In this video, John and Thomas discuss:

  • (1:48): the headwinds & tailwinds facing the healthcare sector
  • (7:10): why they are bullish on Neuren
  • (13:48): opportunities in healthcare stocks for 2025
  • (15:18): what’s on their clinical data radar for the upcoming year.

Under the Radar Report: Blue sky stocks

Richard Hemming
April 22, 2016

Three Quintessential Stocks

Bell Direct
April 13, 2016

Bell Potter Yield Stocks

Bell Direct
April 12, 2016

Market Open

Julia Lee
April 11, 2016

Small cap CEO interview: CV Check

Bell Direct
March 23, 2016

Market Update 14 March 2016

Julia Lee
March 14, 2016

Bell Potter banks march

Bell Direct
March 11, 2016

Portfolio Strategy Builder

Bell Direct
March 7, 2016

Technical Insights Tutorial

Bell Direct
March 7, 2016

Daily Trading Idea Tutorial

Bell Direct
March 7, 2016